NEUROPHET, Inc. (KOSDAQ:380550)
22,000
-1,900 (-7.95%)
Mar 9, 2026, 3:30 PM KST
NEUROPHET Market Cap
NEUROPHET has a market cap or net worth of 266.02 billion as of March 9, 2026.
Market Cap
266.02B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
22,000.00
Market Cap Chart
Since July 25, 2025, NEUROPHET's market cap has increased from 232.96B to 266.02B, an increase of 14.19%. That is a compound annual growth rate of 23.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 266.02B | 2.74% |
| Dec 30, 2025 | 258.91B | 11.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.10T |
| Celltrion | 46.51T |
| ALTEOGEN | 19.95T |
| Sam Chun Dang Pharm. | 17.77T |
| Bio Plus | 312.63B |
| Huons | 306.44B |
| Helixmith | 294.70B |
| Korea United Pharm | 291.76B |